BamSEC and AlphaSense Join Forces
Learn More
You must log in to view this page.

enGene Therapeutics Inc. – Ownership Summary

NASDAQ: ENGN    
Share price (11/17/26): $1.72    
Market cap (11/17/26): $115 million